Pancreatic Cancer Research

ResearcherSendai Medical CenterActive in the last 2 years

Takashi Tsuchiya

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2594-1811; OpenAlex author ID A5005431318. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
7
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: 3 papers

Papers 4

  1. Postoperative Carbohydrate Antigen 19-9 Level as a Good Indicator of Ineffective Response to the Currently Recommended S-1 Adjuvant Chemotherapy for Pancreatic… Last author DOI 10.1245/s10434-023-14440-0↗
  2. ASO Author Reflections: Postoperative Carbohydrate Antigen 19-9 Levels Become a Reliable Biomarker for Establishing Intensity-Stratified Adjuvant Treatments in… Last author DOI 10.1245/s10434-023-14506-z↗
  3. [A Case of Unresectable Locally Advanced Pancreatic Cancer in Which Chemoradiotherapy Achieved Pathological Complete Response]. Last author PMID 39948838↗
  4. Pancreatic Ductal Adenocarcinoma Concomitant with Main Duct Type Intraductal Papillary Mucinous Neoplasm of the Pancreas: A Case Report. Co-author DOI 10.12659/ajcr.932565↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kyohei Ariake · 3 shared papers, 2024 · strength 0.63
  2. Takaho Okada · 3 shared papers, 2021–2024 · strength 0.50
  3. Takayuki Morito · 1 shared paper, 2024 · strength 0.24
  4. Kei Ito · 1 shared paper, 2021 · strength 0.11
  5. Yoshihide Kanno · 1 shared paper, 2021 · strength 0.11
  6. Toshitaka Sakai · 1 shared paper, 2021 · strength 0.11
  7. Keisuke Yonamine · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.